Here is how Bioventus (BVS) and Amneal Pharmaceuticals (AMRX) have performed compared to their secto

A rate hike could keep markets volatile, making BVS, CNC, AMRX and CRON healthcare stocks to conside

Canaccord Genuity analyst Caitlin Cronin maintains Bioventus (NASDAQ:BVS) with a Buy and raises t

Cantor Fitzgerald analyst Sarah James reiterates Bioventus (NASDAQ:BVS) with a Overweight and mai

Major M&A deals include Visa buys BioCatch, Apollo Global nabs EasyJet, QVC emerges from Chapter

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

Bioventus Inc. (BVS) Q2 2026 Earnings Call Transcript

Bioventus NASDAQ: BVS reported second-quarter 2026 revenue growth of 4% and reiterated its full-year

Bioventus (BVS) came out with quarterly earnings of $0.22 per share, in line with the Zacks Consensu

Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.22 per share which met the analyst consensu

Bioventus (NASDAQ:BVS) affirms FY2026 Adj EPS guidance from $0.75-$0.79 to $0.75-$0.79 vs $0.78 anal

DURHAM, N.C., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Co

Wall Street loves to make stock selection sound like a combination of advanced calculus, artificial

Investors spend an enormous amount of time searching for the next stock that can rise 10 times in va

Bioventus (BVS) doesn't possess the right combination of the two key ingredients for a likely earnin

DURHAM, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Co

Here is how Bioventus (BVS) and Aveanna Healthcare (AVAH) have performed compared to their sector so

Forte Biosciences shares rose 38.9% to $76.10 in pre-market trading after argenx SE announced plans

The consensus price target hints at a 28.9% upside potential for Bioventus (BVS). While empirical re

Bioventus (BVS) might move higher on growing optimism about its earnings prospects, which is reflect

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

Does Bioventus (BVS) have what it takes to be a top stock pick for momentum investors? Let's find ou

The mean of analysts' price targets for Bioventus (BVS) points to a 28.8% upside in the stock. While

Bioventus Inc. develops medical devices and biologics for orthopedic recovery and pain relief. I pre

Bioventus (BVS) was a big mover last session on higher-than-average trading volume. The latest trend

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob

Gainers Seer (NASDAQ:SEER) stock moved upwards by 33.3% to $2.16 during Thursday's after-market

FA, BVS and OOMA emerged as July breakout stock picks after meeting momentum and price-based screens

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

On April 16, 2026, the U.S. Food and Drug Administration ("FDA") issued a final order reclas

Bioventus (NASDAQ:BVS) raises FY2026 Adj EPS guidance from $0.73-$0.77 to $0.75-$0.79 vs $0.75 analy

Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.15 per share which beat the analyst consens

Barrington Research analyst Michael Petusky maintains Bioventus (NASDAQ:BVS) with a Outperform an

Craig-Hallum analyst Alexander Nowak maintains Bioventus (NASDAQ:BVS) with a Buy and raises the p

2026 Financial Guidance Bioventus introduced its financial guidance for full-year 2026. The Company

Barrington Research analyst Michael Petusky initiates coverage on Bioventus (NASDAQ:BVS) with a O

2025 Financial Guidance:Bioventus reiterated its 2025 Financial Guidance provided on May 6, 2025, in

Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.21 per share which met the analyst consensu

These two clearances mark an important step forward for Bioventus and represent a substantial growth

Cantor Fitzgerald analyst Ross Osborn initiates coverage on Bioventus (NASDAQ:BVS) with a Overwei